Inogen Future Growth
Future criteria checks 0/6
Inogen is forecast to grow earnings and revenue by 19.5% and 4.4% per annum respectively. EPS is expected to grow by 20.1% per annum. Return on equity is forecast to be -15.3% in 3 years.
Key information
19.5%
Earnings growth rate
20.1%
EPS growth rate
Medical Equipment earnings growth | 17.0% |
Revenue growth rate | 4.4% |
Future return on equity | -15.3% |
Analyst coverage | Low |
Last updated | 12 Dec 2024 |
Recent future growth updates
Recent updates
Inogen: Upside Seems Limited After Big Move Up
Sep 24Inogen, Inc.'s (NASDAQ:INGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jul 16Inogen: Improving, But Still Struggling For Air
Jul 01Inogen, Inc. (NASDAQ:INGN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
May 22Inogen: New Management And A Major Competitor Exit Offer Some New Opportunities
Apr 13Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target
Mar 01Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%
Feb 01Is Inogen (NASDAQ:INGN) In A Good Position To Deliver On Growth Plans?
Oct 06Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business
Jun 21Is Inogen, Inc. (NASDAQ:INGN) Worth US$13.3 Based On Its Intrinsic Value?
Mar 14Companies Like Inogen (NASDAQ:INGN) Can Afford To Invest In Growth
Oct 27Inogen, Inc.'s (NASDAQ:INGN) Intrinsic Value Is Potentially 64% Above Its Share Price
Sep 20Inogen: Structural, Supply Chain Headwinds Remain
Sep 13Inogen Non-GAAP EPS of -$0.02 beats by $0.31, revenue of $103.38M beats by $2.74M
Aug 04Inogen: Seasonal FCF, Tightening Margins, Supply Chain Headwinds
Jun 14At US$35.28, Is It Time To Put Inogen, Inc. (NASDAQ:INGN) On Your Watch List?
Apr 03Hammered By Supply Issues, Inogen Could Be A 2023 Comeback Story
Mar 31Is There An Opportunity With Inogen, Inc.'s (NASDAQ:INGN) 28% Undervaluation?
Mar 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 364 | -32 | -2 | 29 | 3 |
12/31/2025 | 345 | -37 | 21 | 15 | 4 |
12/31/2024 | 330 | -41 | 117 | 145 | 4 |
9/30/2024 | 332 | -53 | -14 | 6 | N/A |
6/30/2024 | 327 | -92 | -20 | 1 | N/A |
3/31/2024 | 322 | -97 | -26 | -2 | N/A |
12/31/2023 | 316 | -102 | -30 | -3 | N/A |
9/30/2023 | 328 | -133 | -43 | -16 | N/A |
6/30/2023 | 349 | -96 | -55 | -27 | N/A |
3/31/2023 | 369 | -90 | -50 | -26 | N/A |
12/31/2022 | 377 | -84 | -59 | -38 | N/A |
9/30/2022 | 366 | -50 | -36 | -16 | N/A |
6/30/2022 | 353 | -28 | -31 | -9 | N/A |
3/31/2022 | 351 | -20 | -20 | 3 | N/A |
12/31/2021 | 358 | -6 | 0 | 24 | N/A |
9/30/2021 | 356 | 11 | 9 | 33 | N/A |
6/30/2021 | 337 | -2 | 20 | 43 | N/A |
3/31/2021 | 307 | -5 | 19 | 39 | N/A |
12/31/2020 | 308 | -6 | 19 | 37 | N/A |
9/30/2020 | 313 | -2 | 16 | 30 | N/A |
6/30/2020 | 331 | 6 | 29 | 38 | N/A |
3/31/2020 | 360 | 14 | 36 | 43 | N/A |
12/31/2019 | 362 | 21 | 34 | 41 | N/A |
9/30/2019 | 370 | 32 | 37 | 44 | N/A |
6/30/2019 | 373 | 42 | 34 | 43 | N/A |
3/31/2019 | 369 | 46 | 35 | 46 | N/A |
12/31/2018 | 358 | 52 | 47 | 60 | N/A |
9/30/2018 | 335 | 41 | 44 | 61 | N/A |
6/30/2018 | 309 | 32 | N/A | 64 | N/A |
3/31/2018 | 276 | 26 | N/A | 60 | N/A |
12/31/2017 | 249 | 21 | N/A | 60 | N/A |
9/30/2017 | 237 | 27 | N/A | 53 | N/A |
6/30/2017 | 222 | 25 | N/A | 44 | N/A |
3/31/2017 | 212 | 24 | N/A | 39 | N/A |
12/31/2016 | 203 | 21 | N/A | 31 | N/A |
9/30/2016 | 192 | 19 | N/A | 38 | N/A |
6/30/2016 | 179 | 17 | N/A | 41 | N/A |
3/31/2016 | 168 | 13 | N/A | 37 | N/A |
12/31/2015 | 159 | 12 | N/A | 38 | N/A |
9/30/2015 | 148 | 9 | N/A | 30 | N/A |
6/30/2015 | 136 | 9 | N/A | 21 | N/A |
3/31/2015 | 123 | 7 | N/A | 23 | N/A |
12/31/2014 | 113 | 5 | N/A | 16 | N/A |
9/30/2014 | 103 | 6 | N/A | 13 | N/A |
6/30/2014 | 94 | 3 | N/A | 15 | N/A |
3/31/2014 | 83 | 1 | N/A | 9 | N/A |
12/31/2013 | 75 | 0 | N/A | 13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: INGN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: INGN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: INGN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: INGN's revenue (4.4% per year) is forecast to grow slower than the US market (9.1% per year).
High Growth Revenue: INGN's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: INGN is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 14:27 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Inogen, Inc. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Robert Marcus | J.P. Morgan |
Matthew Mishan | KeyBanc Capital Markets Inc. |
Jeffrey Cohen | Ladenburg Thalmann & Company |